{
    "2020-08-26": [
        [
            {
                "time": "2020-08-26",
                "original_text": "复星医药：业绩拐点逐步确认，创新增量提速带动产品结构调整",
                "features": {
                    "keywords": [
                        "复星医药",
                        "业绩拐点",
                        "创新增量",
                        "产品结构调整"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-26",
                "original_text": "复星医药CEO谈全球首例新冠二次感染：更说明疫苗的必要性",
                "features": {
                    "keywords": [
                        "复星医药",
                        "新冠疫苗",
                        "二次感染",
                        "疫苗必要性"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-08-26",
                "original_text": "复星医药子公司获美洛昔康片《药品生产许可证》",
                "features": {
                    "keywords": [
                        "复星医药",
                        "美洛昔康片",
                        "药品生产许可证"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-08-26",
                "original_text": "复星医药总裁吴以芳：国内有望与国外同步，于10月寻求新冠mRNA疫苗上市申请",
                "features": {
                    "keywords": [
                        "复星医药",
                        "新冠mRNA疫苗",
                        "上市申请",
                        "国内外同步"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-26",
                "original_text": "中报业绩披露临近尾声 震荡市中关注行业景气度高的板块",
                "features": {
                    "keywords": [
                        "中报业绩",
                        "震荡市",
                        "行业景气度"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-08-26",
                "original_text": "A股大幅回调，创业板跌逾2%！但这个板块火了，3只个股20%涨停，资金大幅涌入",
                "features": {
                    "keywords": [
                        "A股",
                        "创业板",
                        "回调",
                        "资金流入"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-08-26",
                "original_text": "复星医药半年度实现净利17.15亿元 同比增长13.10%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "半年度净利",
                        "同比增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}